Pasteur Laboratory, Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.
Department of Infectious Diseases, Istituto Superiore Sanità, Rome, Italy.
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01551-20.
Dengue virus (DENV) is a mosquito-borne virus that infects upward of 300 million people annually and has the potential to cause fatal hemorrhagic fever and shock. While the parameters contributing to dengue immunopathogenesis remain unclear, the collapse of redox homeostasis and the damage induced by oxidative stress have been correlated with the development of inflammation and progression toward the more severe forms of disease. In the present study, we demonstrate that the accumulation of reactive oxygen species (ROS) late after DENV infection (>24 hpi) resulted from a disruption in the balance between oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent antioxidant response. The DENV NS2B3 protease complex strategically targeted Nrf2 for degradation in a proteolysis-independent manner; NS2B3 licensed Nrf2 for lysosomal degradation. Impairment of the Nrf2 regulator by the NS2B3 complex inhibited the antioxidant gene network and contributed to the progressive increase in ROS levels, along with increased virus replication and inflammatory or apoptotic gene expression. By 24 hpi, when increased levels of ROS and antiviral proteins were observed, it appeared that the proviral effect of ROS overcame the antiviral effects of the interferon (IFN) response. Overall, these studies demonstrate that DENV infection disrupts the regulatory interplay between DENV-induced stress responses, Nrf2 antioxidant signaling, and the host antiviral immune response, thus exacerbating oxidative stress and inflammation in DENV infection. Dengue virus (DENV) is a mosquito-borne pathogen that threatens 2.5 billion people in more than 100 countries annually. Dengue infection induces a spectrum of clinical symptoms, ranging from classical dengue fever to severe dengue hemorrhagic fever or dengue shock syndrome; however, the complexities of DENV immunopathogenesis remain controversial. Previous studies have reported the importance of the transcription factor Nrf2 in the control of redox homeostasis and antiviral/inflammatory or death responses to DENV. Importantly, the production of reactive oxygen species and the subsequent stress response have been linked to the development of inflammation and progression toward the more severe forms of the disease. Here, we demonstrate that DENV uses the NS2B3 protease complex to strategically target Nrf2 for degradation, leading to a progressive increase in oxidative stress, inflammation, and cell death in infected cells. This study underlines the pivotal role of the Nrf2 regulatory network in the context of DENV infection.
登革热病毒(DENV)是一种通过蚊子传播的病毒,每年感染人数超过 3 亿,有可能导致致命性出血热和休克。虽然导致登革热免疫发病机制的因素仍不清楚,但氧化应激引起的氧化还原平衡崩溃和损伤与炎症的发展和向更严重疾病形式的进展有关。在本研究中,我们证明 DENV 感染后(>24 hpi)活性氧(ROS)的积累是由于氧化应激与核因子红细胞 2 相关因子 2(Nrf2)依赖性抗氧化反应之间的平衡被破坏所致。DENV NS2B3 蛋白酶复合物以非蛋白水解方式将 Nrf2 靶向进行降解;NS2B3 使 Nrf2 许可进行溶酶体降解。NS2B3 复合物对 Nrf2 调节剂的损伤抑制了抗氧化基因网络,并导致 ROS 水平的持续升高,同时增加了病毒复制以及炎症或凋亡基因的表达。到 24 hpi 时,观察到 ROS 和抗病毒蛋白水平升高,似乎 ROS 的促病毒作用超过了干扰素(IFN)反应的抗病毒作用。总体而言,这些研究表明,DENV 感染破坏了 DENV 诱导的应激反应、Nrf2 抗氧化信号和宿主抗病毒免疫反应之间的调节相互作用,从而加剧了 DENV 感染中的氧化应激和炎症。登革热病毒(DENV)是一种通过蚊子传播的病原体,每年在 100 多个国家威胁着 25 亿人。登革热感染会引起一系列临床症状,从典型的登革热到严重的登革出血热或登革休克综合征不等;然而,DENV 免疫发病机制的复杂性仍存在争议。先前的研究报告了转录因子 Nrf2 在控制氧化还原平衡以及对 DENV 的抗病毒/炎症或死亡反应中的重要性。重要的是,活性氧的产生和随后的应激反应与炎症的发展和向更严重疾病形式的进展有关。在这里,我们证明 DENV 使用 NS2B3 蛋白酶复合物将 Nrf2 作为降解的靶点,导致感染细胞中氧化应激、炎症和细胞死亡的逐渐增加。这项研究强调了 Nrf2 调节网络在 DENV 感染中的关键作用。